# A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

> **NCT02164266** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteer, Type 2 Diabetes

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO6799477

## Key facts

- **NCT ID:** NCT02164266
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02164266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02164266, "A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02164266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*